Summit Therapeutics Aktie
WKN DE: A14P7C / ISIN: US86627R1023
23.03.2025 10:49:00
|
Is Summit Therapeutics a Millionaire Maker?
Multiple paths to immense wealth exist. A few lucky people win the lottery. Some start successful businesses. Others invest in stocks that deliver explosive gains.Summit Therapeutics (NASDAQ: SMMT) is one of those stocks that have been quite explosive: The share price of the clinical-stage drugmaker has skyrocketed by nearly 390% over the last 12 months. But is Summit Therapeutics a millionaire-maker?We can explain Summit Therapeutics' remarkable stock performance with just one word: ivonescimab. That's the cancer drug Summit licensed from Chinese drugmaker Akeso (OTC: AKES.F) in 2022.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Summit Therapeutics PLC (spons. ADRs)mehr Nachrichten
Keine Nachrichten verfügbar. |